Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Seagen is a biotechnology company that develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
Investors are cheering Pfizer's planned acquisition of Seagen.
Rumors of another buyout are pushing the drugmaker's shares higher today.
SGEN earnings call for the period ending December 31, 2022.
SGEN earnings call for the period ending September 30, 2022.
SGEN earnings call for the period ending June 30, 2022.
SGEN earnings call for the period ending March 31, 2022.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.